ASHLEY SEE: Open Payments
NPI 1467892380 · LOUISA, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,155 in 62 payments from 18 companies in 2025. Trend: 2023 $372 · 2024 $420 · 2025 $1,155
Food & beverage: $1,155
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 17 | $239 |
| Verona Pharma, Inc. | 12 | $180 |
| ABBVIE INC. | 5 | $122 |
| Viatris Specialty LLC | 3 | $99 |
| GENZYME CORPORATION | 4 | $96 |
| AstraZeneca Pharmaceuticals LP | 4 | $66 |
| Grifols USA, LLC | 2 | $52 |
| Lilly USA, LLC | 3 | $48 |
| Amgen Inc. | 2 | $38 |
| Genentech USA, Inc. | 2 | $37 |
Products named: TRELEGY ELLIPTA, Ohtuvayre, YUPELRI, DUPIXENT, QULIPTA, Prolastin-C Liquid, MOUNJARO, TEZSPIRE.
Industry payments across KY — which companies pay providers there.
